July 2021
• The Center for Disease Control and Prevention’s Opioid Workgroup delivered its report on proposed revisions to its prescribing guidelines. NPAC’s President and Advisors appointed members of the Workgroup, and NPAC provided testimony at the CDC’s meeting related to the report.